These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
691 related articles for article (PubMed ID: 12130768)
1. Parasitology. Malaria--from infants to genomics to vaccines. Long CA; Hoffman SL Science; 2002 Jul; 297(5580):345-7. PubMed ID: 12130768 [No Abstract] [Full Text] [Related]
2. The hope but challenge for developing a vaccine that might control malaria. Good MF Eur J Immunol; 2009 Apr; 39(4):939-43. PubMed ID: 19350585 [TBL] [Abstract][Full Text] [Related]
3. Functional genomics, new tools in malaria research. Di Girolamo F; Raggi C; Bultrini E; Lanfrancotti A; Silvestrini F; Sargiacomo M; Birago C; Pizzi E; Alano P; Ponzi M Ann Ist Super Sanita; 2005; 41(4):469-77. PubMed ID: 16569915 [TBL] [Abstract][Full Text] [Related]
4. Malaria vaccines: scientific and ethical issues. Tosta CE Rev Inst Med Trop Sao Paulo; 1992 Apr; 34 Suppl 9():S33-40. PubMed ID: 1340632 [No Abstract] [Full Text] [Related]
6. Malaria. A complex new vaccine shows promise. Vogel G Science; 2004 Oct; 306(5696):587-9. PubMed ID: 15498976 [No Abstract] [Full Text] [Related]
7. Malaria vaccines: the stage we are at. Todryk SM; Hill AV Nat Rev Microbiol; 2007 Jul; 5(7):487-9. PubMed ID: 17571459 [No Abstract] [Full Text] [Related]
8. Parasitology. Malaria vaccines: back to the future? Waters AP; Mota MM; van Dijk MR; Janse CJ Science; 2005 Jan; 307(5709):528-30. PubMed ID: 15681372 [No Abstract] [Full Text] [Related]
9. Overview: immunology of malaria and progress in malaria vaccine development. Tharavanij S Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871 [No Abstract] [Full Text] [Related]
10. The dog that did not bark: malaria vaccines without antibodies. Heppner DG; Schwenk RJ; Arnot D; Sauerwein RW; Luty AJ Trends Parasitol; 2007 Jul; 23(7):293-6. PubMed ID: 17512252 [TBL] [Abstract][Full Text] [Related]
11. Peripheral T-cell non-responsiveness in individuals exposed to Plasmodium falciparum malaria. Hviid L APMIS Suppl; 1995; 53():1-46. PubMed ID: 9409941 [No Abstract] [Full Text] [Related]
12. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles. Lalitha PV; Biswas S; Pillai CR; Saxena RK Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786 [TBL] [Abstract][Full Text] [Related]
14. Host responsiveness to malaria epitopes and immunopathology. Del Giudice G; Grau GE; Lambert PH Prog Allergy; 1988; 41():288-330. PubMed ID: 2457218 [No Abstract] [Full Text] [Related]
15. [The immunological aspects of tropical malaria related to the development of an antimalarial vaccine]. Chirkov VP; Popov AF Med Parazitol (Mosk); 2000; (2):56-8. PubMed ID: 10900926 [No Abstract] [Full Text] [Related]
16. Vaccinating with the genome: a Sisyphean task? Coppel RL Trends Parasitol; 2009 May; 25(5):205-12. PubMed ID: 19359219 [TBL] [Abstract][Full Text] [Related]
17. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria? Nebie I; Tiono AB; Diallo DA; Samandoulougou S; Diarra A; Konate AT; Cuzin-Ouattara N; Theisen M; Corradin G; Cousens S; Ouattara AS; Ilboudo-Sanogo E; Sirima BS Trop Med Int Health; 2008 Feb; 13(2):229-37. PubMed ID: 18304269 [TBL] [Abstract][Full Text] [Related]
18. Malaria vaccines: from laboratory to field. Epidemiol Bull; 1994 Mar; 15(1):1-8. PubMed ID: 8011432 [No Abstract] [Full Text] [Related]